logo
Barely Sleep and Still Feel Fine? Thank Your Lucky Genes

Barely Sleep and Still Feel Fine? Thank Your Lucky Genes

Gizmodo12-05-2025
Boy, some people have all the genetic luck. In a recent study, scientists describe a newly discovered mutation that allows humans to naturally sleep much fewer hours a night without any negative health effects.
Researchers in China conducted the study, published in Proceedings of the National Academy of Sciences. The mutation was found in a 70-year-old healthy woman who's lived her whole life barely sleeping. The findings could someday help us understand how to better treat sleep disorders that plague the rest of humanity, the researchers say.
Most people need around seven to nine hours of sleep a night for optimal health. But there are some out there who are so-called natural short sleepers, able to rest between four and six hours every night without experiencing the symptoms of sleep deprivation (not to be confused with the roughly one-third of people who sleep less than seven hours a night and suffer for it). Research has found that these individuals tend to carry unique genetic mutations.
So far, scientists have found mutations in four different genes (DEC2, NPSR1, GRM1, and ADRB1) tied to natural short sleep. But the researchers behind this new study have now found another: the salt-inducible kinase 3, or SIK3, gene, named after the protein it makes. SIK3 is a protein kinase, a type of enzyme. It's thought to play a role in our metabolism, but past research (mostly in mice) has also suggested that it helps influence sleep duration.
The team analyzed the sleeping patterns and DNA of their volunteer. Though she reported usually only needing three hours of sleep a night, actigraphy recordings (movement at night typically captured via wristwatch) found that she actually slept a still very breezy 6.3 hours a night on average. The team's genetic exploration also identified a particular mutation in the SIK3 gene—dubbed N783Y—that seemed to explain her natural short sleep.
To confirm their discovery, they engineered mice with the same mutation, and found that they too slept less than normal mice did. The mutation appears to inhibit SIK3's ability to transfer certain molecules to other proteins as usual, particularly proteins important to the synapses, the connections that form between neurons.
'These findings underscore the conserved function of SIK3 as a critical gene in human sleep regulation,' the authors wrote.
Perhaps only around 1% of the world's population are natural short sleepers. But the lessons we learn from unraveling their unique genetic gift could help scientists find new drug targets for treating sleep disorders. The study researchers have already found some evidence that other protein kinases similar to SIK3 also play a part in affecting our sleep duration.
'These findings advance our understanding of the genetic underpinnings of sleep, highlight the broader implications of kinase activity in sleep regulation across species, and provide further support for potential therapeutic strategies to enhance sleep efficiency,' they wrote.
In any case, here's hoping scientists also discover the genetic reason why my cat has to wake me up at 6 in the morning rain or shine, despite knowing that breakfast is hours away.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Philippines' Ayala Corp. To Sell Minority Stake In AC Health To Temasek's ABC Impact
Philippines' Ayala Corp. To Sell Minority Stake In AC Health To Temasek's ABC Impact

Forbes

time10 minutes ago

  • Forbes

Philippines' Ayala Corp. To Sell Minority Stake In AC Health To Temasek's ABC Impact

AC Health operates a network of pharmacies, clinics and hospitals across the Philippines. Courtesy of Ayala Corp AC Health—a wholly-owned subsidiary of billionaire Jaime Zobel de Ayala and his family 's Ayala Corp.—is selling a 16% stake for an undisclosed amount to ABC Impact, a Singapore-based investor backed by Temasek. In its maiden Philippine venture, ABC Impact will inject primary capital into the healthcare company, supporting the Philippine company's expansion, AC Health said in a statement. ABC Impact has a regional portfolio that includes investments in India, China, and Vietnam. 'ABC Impact's investment reinforces the strength of our integrated model and our commitment to making healthcare more inclusive,' AC Health CEO Paolo Borromeo said. Ayala Corp. said in April it aims to grow AC Health into becoming its next unicorn with $2 billion in equity valuation by 2035, four times its current value. Founded a decade ago, AC Health has been building up its hospitals, multi-specialty clinics, and retail pharmacies through organic growth and acquisitions. By 2027, AC Health aims to expand its network to at least 10 hospitals, 300 clinics, and 1,150 pharmacies. In April, it had 880 drugstores, two drug importers licensed to distribute over 1,178 medicines, 236 corporate and multi-specialty clinics and six hospitals under Healthway Medical. ABC Impact's investment follows a strategic partnership AC Health entered into last week with Dexa Group, one of Indonesia's largest pharmaceutical companies, to import and distribute medicines into the Philippines. Ayala Corp. has invested 15 billion pesos ($263 million) since 2015 into AC Health, which posted a net loss of 610 million in 2024 as asset impairment charges and costs of its new cancer center eroded a 10% increased in sales to 9.4 billion pesos. 'This partnership with Ayala and AC Health reflects our mission to improve lives by advancing access to quality care,' ABC Impact CEO David Heng said. 'Through our regional healthcare experience and impact lens, we aim to support AC Health's efforts to strengthen systems and serve more communities across the Philippines." Ayala Corp., the country's oldest conglomerate, was started by the great grandfather of Jaime Zobel de Ayala , the family patriarch, in 1834 as a distillery. Today, the Manila-listed company has interests in banking, energy, logistics, utilities and real estate. With a net worth of $3.4 billion, the family ranks seventh among the richest in the Philippines.

Scientists Design Huge Spacecraft That Could Carry 2,400 Colonists to Alpha Centauri
Scientists Design Huge Spacecraft That Could Carry 2,400 Colonists to Alpha Centauri

Yahoo

time26 minutes ago

  • Yahoo

Scientists Design Huge Spacecraft That Could Carry 2,400 Colonists to Alpha Centauri

A team of engineers has come up with designs of a 36-mile spacecraft, dubbed Chrysalis, designed to carry up to 2,400 passengers to Alpha Centauri, the closest star system to our own. As first spotted by Live Science, the ambitious vision recently won the team the top prize at the Project Hyperion Design Competition, which was launched last year by an international consortium of scientists, engineers, and urban planners. Unsurprisingly, Chrysalis sounds like it was yanked straight out of a sci-fi novel. The hypothetical habitat generates Earth-like gravity by constantly rotating around its own axis, as laid out in a project brief. Several onion-like layers include dwellings and gardens for inhabitants, warehouses, food production and ecosystems, and communal spaces. Each of these shells is powered by nuclear fusion reactors — which, it's fair to point out, is tech that hasn't been yet been made practical by anybody here on Earth. Chrysalis is made up of several stages, each of which is a "fully autonomous and complete" habitat. The layer closest to the core was designed to provide space for plants, microbes, livestock, and other mechanisms of food production. Various environments allow biodiversity to continue, including tropical and boreal forests. The second layer houses communal spaces, and the third holds "3D-printed dwelling modules." The outermost shell serves as a warehouse for machinery, equipment, and other types of resources. A "Cosmos Dome," 426 feet in height and 1,180 feet in diameter, provides a controlled, zero-gravity environment, as well as thermal insulation and shielding from deep space radiation. It's also the only place where inhabitants can gaze at the universe outside, while freely and safely floating around in weightlessness. "Through the transparent panels of the dome, the inhabitants will be able to observe the universe to the rear of the spaceship," the brief reads. Since Chrysalis is a generational ship, the goal is to give both male and female inhabitants a three-year window between the ages of 28 and 31 to reproduce. There's a two-child limit for each inhabitant, "not necessarily with the same partner," according to the brief. The goal is to maintain a "stable population" of roughly 1,500 individuals over three generations. An artificial intelligence would allow for "resilience of the whole social system, better knowledge transfer between the different generations of inhabitants and a deeper vision of the overall dynamics of the Chrysalis spaceship complex," the pitch reads. While it's a fascinating and detailed vision of an exciting, multi-generational journey to a different star system, Chrysalis is still firmly in the realm of science fiction. Beyond the pesky issue of nuclear fusion not yet existing in a practical form, the manufacturing processes required to build a tens-of-miles structure in zero gravity far surpass anything humanity has accomplished yet. We haven't even fully explored the concept of artificial gravity with the help of a centrifuge. But that doesn't mean we shouldn't explore the concept — especially in the face of various potential disasters that could threaten humanity's future on Earth. More on generational ships: Researchers Plotting Giant Spaceship That Could Carry Generations of Humans

Venture capital firm Speciale Invest to back Indian startups with $69 million by 2029
Venture capital firm Speciale Invest to back Indian startups with $69 million by 2029

Yahoo

timean hour ago

  • Yahoo

Venture capital firm Speciale Invest to back Indian startups with $69 million by 2029

(Reuters) -India's Speciale Invest will invest 6 billion rupees ($69 million) over the next four years in early-stage startups spanning across sectors including artificial intelligence and space technology, the venture capital company said on Tuesday. The investment into "deep-tech" - innovations that require significant scientific research breakthroughs - comes as Prime Minister Narendra Modi aims to make India a "self-reliant" manufacturing hub and amid shifting trade relations globally, spurred by U.S. President Donald Trump's tariff policy. Founded in 2017, Speciale Invest focusses on investing in companies that are at the "seed" and "pre-seed" level of fundraising. It has previously backed air taxi startup ePlane Company and space startup Agnikul Cosmos, which launched India's second privately-built rocket last year. As part of its third funding round, the venture capital company will invest in 18 to 20 companies through 2029, with initial ticket sizes between 70 million rupees and 100 million rupees, it said. More than half of the $69 million will be reserved for follow-on investments, with some of the targets hailing from climate technology and dual-use defence sectors, it added. ($1 = 87.6050 Indian rupees)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store